...of a B7-H4 targeting antibody drug conjugate (ADC) in...
TP012/#1420XMT-1660: a phase 1B trial of a B7-H4 targeting antibody drug conjugate (ADC) in endometrial, ovarian, and breast cancersdoi:10.1136/ijgc-2022-igcs.521Objectives Endometrial (EC) and ovarian cancers (